跳至主要内容
临床试验/NCT05416294
NCT05416294Unknown不适用

Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries

DyAnsys, Inc.0 个研究点目标入组 44 人开始时间: 2022年8月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
DyAnsys, Inc.
入组人数
44
主要终点
Numerical Pain Rating Scale (NPRS)

研究概览

简要总结

To study and evaluate the effect of using the Primary Relief PENS treatment as adjuvant analgesia for reducing pain in total knee replacement (TKR) patients.

详细描述

It is a common knowledge that total knee replacement (TKR) surgeries produce great deal of pain in the postoperative period. Superior pain relief is justifiably needed and usually provided. In addition to the conventional methods of pain relief such as continuous epidural block, intrathecal adjuvants, femoral nerve block ± sciatic nerve block, transcutaneous electrical nerve stimulation (TENS) and percutaneous electrical neurostimulation (PENS) have been reported effective by various authors. Recently neurostimulation of auricular nerves via the external auricular surface has shown to alleviate pain after caesarian section. Primary Relief® is percutaneous electrical neuro stimulator designed to administer auricular neurostimulation treatment over 240 hours. Stimulation is performed by sending electrical pulses emitted through needles strategically positioned in the ear. The ear provides numerous points for stimulation within a small area Based on the area of pain relief, chosen points are stimulated. Primary Relief is a miniaturized device designed to administer PENS treatment. Use of this device is recommended for pre-operative, intra-operative and post-operative pain therapy as well as for the treatment of chronic pain.

An advantage over drug therapy is that it avoids the possible side-effects of analgesics and helps in early mobilization following orthopedic surgeries including total knee replacement (TKR), total hip replacement (THR) and shoulder surgeries. Therefore, this study is being undertaken to assess the effect of Primary Relief ® in augmenting pain relief after TKR surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing TKR under regional or general anesthesia and femoral nerve block who consent to participate in the study.

排除标准

  • ASA 3 or 4
  • Those receiving psychiatric medication
  • Those with infection at the site of application.
  • The following data will be collected
  • Intraoperative use of local anesthetics, opioids and other analgesics
  • Postoperative details as to the time of application of the device. NPRS in both the groups at multiple intervals, on demand analgesic requirement, overall analgesic consumption during the study period, quality of life questionnaire at the end of the study period and relevant postoperative complications will be noted.
  • Rescue analgesics will be considered for breakthrough pain or NPRS >
  • Intravenous Tramadol 50mg will be the first rescue analgesic and if pain is not relieved with Tramadol, opiods will be considered. Non steroidal anti inflammatory drugs will be considered to supplement the above medications if there is no contraindication and if need arises.
  • NPRS score will be noted at multiple intervals for 10 days.
  • Any nausea, vomiting, giddiness, intolerance to the device will also be noted.
  • During the follow up, quality of life questionnaire would be administered and the result noted.
  • The device will be removed after 10 days of its application. Any redness at the site of application or pain at the site are noted. The study will end with the removal of the device.

结局指标

主要结局

Numerical Pain Rating Scale (NPRS)

时间窗: 0 - 3 days ; 0,2,4,6,8,10,12,18,24,36,48,60,72 hrs from the time of completion of surgery

To evaluate the pain score in the immediate postoperative period. Pain Score with will be measured on a scale (0 = no pain; 10 = worst imaginable pain).

次要结局

  • KOOS Score The Knee injury and Osteoarthritis Outcome Score ( koos)(5 times planned from 0 - 10 day; (i) 24 hrs before Surgery; (ii) 24 Hrs after completion of surgery; (iii) 72 hrs after completion of Surgery; (iv) 120 hrs after completion of Surgery; (v) At the time of device removal -@240 hrs))
  • NPRS Numerical Pain Rating Scale score post-mobilization(4 - 10 days ; 96,120,144,168,192,216,240 hrs from the time of completion of surgery))
  • Total Use of Analgesics and Opioids(OVERALL DOSE IN FIRST 3 DAYS & OVERALL DOSE REQUIRED BETWEEN 4 TO 10 DAYS)

研究者

发起方
DyAnsys, Inc.
申办方类型
Industry
责任方
Sponsor

相似试验